| 注册
首页|期刊导航|中国药物经济学|精神分裂症稳定期两种治疗方案的成本-效果比较

精神分裂症稳定期两种治疗方案的成本-效果比较

何汝帮 刘宜森 蔡小连

中国药物经济学Issue(2):8-10,3.
中国药物经济学Issue(2):8-10,3.

精神分裂症稳定期两种治疗方案的成本-效果比较

The cost-effectiveness analysis of two schemes in patients with the stable phase of schizophrenia

何汝帮 1刘宜森 2蔡小连3

作者信息

  • 1. 佛山市第三人民医院,广东佛山 528041
  • 2. 佛山科学技术学院,广东佛山 528000
  • 3. 佛山市普达美生物医药科技有限公司,广东佛山 528000
  • 折叠

摘要

Abstract

[Abstrace]Objective To investigate the effect of schizophrenia stable period with atypical antipsychotic treatment cost.Methods Using pharmacoeconomic model of decision tree analysis method,the choice of treatment plan evaluation cost minimum expectations of atypical antipsychotics treatment effect.Results In a year of stable period, so that patients with stable disease,long-acting injection treatment scheme of palmitic acid Paley cefoperazone injection in the treatment of risperidone and plan costs were 19 539.2 yuan and 17 187.6 yuan;and the desired treatment cost corresponding respectively is 36 183.7 yuan and 35 807.4 yuan.Conclusion Risperidone long-acting injection in the treatment of schizophrenia and stable period solution treatment are better for the spirit,and it cost less.

关键词

精神分裂症/非典型抗精神病药物/决策树分析

Key words

Schizophrenia/Atypical antipsychotics/Decision tree analysis

分类

医药卫生

引用本文复制引用

何汝帮,刘宜森,蔡小连..精神分裂症稳定期两种治疗方案的成本-效果比较[J].中国药物经济学,2015,(2):8-10,3.

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文